The Grenfell Tower Inquiry was established after the terrible fire at Grenfell Tower on 14 June 2017. The Inquiry’s remit was wide: not only to investigate the circumstances surrounding the Grenfell ...
Xilio reports a 27% response rate in MSS CRC patients, showing promising biomarker decreases and favorable safety profile with vilastobart. Initial data show only a 27% preliminary response rate in a ...
Phase 1b trial shows 40% response rate for onvansertib plus paclitaxel in metastatic triple-negative breast cancer, with manageable toxicity. Cardiff Oncology, Inc. announced promising results from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results